Adolescents and young adults ages 15 to 39 who are diagnosed with cancer (AYA survivors) undergo a range of therapies for cancer cure, but subsequently may be at risk of treatment-related infertility and, for female AYA survivors, adverse pregnancy outcomes. Future fertility is important to AYA survivors. Meeting their fertility goals requires awareness of this importance, knowledge of cancer treatment-related fertility risks, appropriate fertility counseling on these risks, and access to fertility care. Epidemiologic and dissemination and implementation research are needed to estimate more precise risks of traditional and novel cancer therapies on fertility and pregnancy outcomes and improve the delivery of fertility care.